- Home
- MKZR vs VNRX Comparison
MKZR vs VNRX Comparison
Compare MKZR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- VNRX
- Stock Information
- Founded
- MKZR 2012
- VNRX N/A
- Country
- MKZR United States
- VNRX United States
- Employees
- MKZR N/A
- VNRX N/A
- Industry
- MKZR
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MKZR
- VNRX Health Care
- Exchange
- MKZR Nasdaq
- VNRX Nasdaq
- Market Cap
- MKZR 56.6M
- VNRX 59.6M
- IPO Year
- MKZR N/A
- VNRX N/A
- Fundamental
- Price
- MKZR $2.41
- VNRX $0.63
- Analyst Decision
- MKZR
- VNRX Strong Buy
- Analyst Count
- MKZR 0
- VNRX 4
- Target Price
- MKZR N/A
- VNRX $4.17
- AVG Volume (30 Days)
- MKZR 97.8K
- VNRX 154.8K
- Earning Date
- MKZR 01-01-0001
- VNRX 11-14-2024
- Dividend Yield
- MKZR 7.26%
- VNRX N/A
- EPS Growth
- MKZR N/A
- VNRX N/A
- EPS
- MKZR N/A
- VNRX N/A
- Revenue
- MKZR $17,563,335.00
- VNRX $1,285,827.00
- Revenue This Year
- MKZR N/A
- VNRX $71,446.31
- Revenue Next Year
- MKZR N/A
- VNRX N/A
- P/E Ratio
- MKZR N/A
- VNRX N/A
- Revenue Growth
- MKZR N/A
- VNRX 97.50
- 52 Week Low
- MKZR $1.05
- VNRX $0.43
- 52 Week High
- MKZR $5.50
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- MKZR N/A
- VNRX 48.89
- Support Level
- MKZR N/A
- VNRX $0.61
- Resistance Level
- MKZR N/A
- VNRX $0.65
- Average True Range (ATR)
- MKZR 0.00
- VNRX 0.05
- MACD
- MKZR 0.00
- VNRX 0.00
- Stochastic Oscillator
- MKZR 0.00
- VNRX 38.10
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.